-
Public health officials have relied on sparse data about HIV transmission in prisons, even while knowing that HIV infection rates among prisoners typically are higher than in the general population.
-
The Forum for Collaborative HIV Research and the FDA's Division of Antiviral Products hosted an open public meeting on May 31, 2006, to discuss issues regarding the development of CCR5 co-receptor antagonists for the treatment of HIV infection. Those who were unable to attend the meeting, may view it via a Webcast until June 2007.
-
The United States wielded its power at the United Nations' high-level review meeting on HIV/AIDS in early June and weakened a political declaration by opposing the setting of clear targets and time frames for stopping the epidemic, critics say.
-
The President's Emergency Plan for AIDS Relief (PEPFAR) basic requirements have created confusion and problems for many countries receiving the funds, according to a recent report by the U.S. Government Accountability Office (GAO).
-
Two new international reports highlight the world's continuing failure to rein in the AIDS epidemic in sub-Saharan Africa and in other economically-challenged regions.
-
When money and time are put into HIV prevention efforts, they can have a dramatic impact, and the United States is a good example of this. But the reverse also is true, HIV prevention experts say.
-
AIDS Alert: I have spoken with HIV prevention scientists who have talked about a chilling effect on the research from this administration and Congress in recent years. They say they believe the research will not be funded if it targets certain populations or uses certain words.
-
-
Despite advances in health care and access to more sophisticated diagnostic and treatment modalities, acute bacterial meningitis (ABM) remains a significant cause of morbidity and mortality within the pediatric population.
-
